Ontology highlight
ABSTRACT:
SUBMITTER: Patel SM
PROVIDER: S-EPMC2913582 | biostudies-literature | 2010 Apr
REPOSITORIES: biostudies-literature
Patel Shital M SM Atmar Robert L RL El Sahly Hana M HM Cate Thomas R TR Keitel Wendy A WA
Vaccine 20091118 17
In a phase I clinical trial, one hundred healthy young adults were randomized to receive two doses 28 days apart of an inactivated, subvirion vaccine containing 15 or 45microg of influenza A/H5N1 hemagglutinin (HA) by the intramuscular (IM) route, or 3 or 9microg of H5 HA by the intradermal(ID) route. Seventy-seven subjects received a third dose. All regimens were safe and well tolerated. Antibody responses after two or three doses were low (<or=20% or <or=38%, respectively) and similar in group ...[more]